Pacira BioSciences , Nasdaq: PCRX
Developing a non-opioid postsurgical analgesic pending FDA approval.
Industry: Health Care
First Day Return: +0.3%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 11/01/2010 |
| Offer Price | $7.00 |
| Price Range $7.00 - $7.00 | |
| Offer Shares (mm) | 6.0 |
| Deal Size ($mm) | $42 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/02/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $42 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Parsippany, NJ, United States |
| Founded | 2006 |
| Employees at IPO | 83 |
| Website www.pacira.com | |
Pacira BioSciences (PCRX) Performance
